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Supported lipid bilayerHuntington's Disease (HD) is a neurodegenerative disorder that is deﬁned by the accumulation of nanoscale
aggregates comprised of the huntingtin (htt) protein. Aggregation is directly caused by an expanded
polyglutamine (polyQ) domain in htt, leading to a diverse population of aggregate species, such as oligomers,
ﬁbrils, and annular aggregates. Furthermore, the length of this polyQ domain is directly related to onset and
severity of disease. The ﬁrst 17 N-terminal amino acids of htt have been shown to further modulate aggrega-
tion. Additionally, these 17 amino acids appear to have lipid binding properties as htt interacts with a variety
of membrane-containing structures present in cells, such as organelles, and interactions with these mem-
brane surfaces may further modulate htt aggregation. To investigate the interaction between htt exon1 and
lipid bilayers, in situ atomic force microscopy (AFM) was used to directly monitor the aggregation of htt
exon1 constructs with varying Q-lengths (35Q, 46Q, 51Q, and myc-53Q) on supported lipid membranes com-
prised of total brain lipid extract. The exon1 fragments accumulated on the lipid membranes, causing disrup-
tion of the membrane, in a polyQ dependent manner. Furthermore, the addition of an N-terminal myc-tag to
the htt exon1 fragments impeded the interaction of htt with the bilayer.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Huntington's disease (HD), a fatal neurodegenerative disorder, is
caused by a CAG repeat encoding a polyglutamine (polyQ) expansion
within the ﬁrst exon of huntingtin (htt) [1]. There are ten known ex-
panded CAG repeat diseases in which polyQ expansion beyond a spe-
ciﬁc threshold length results in progressive neurodegeneration [2]. In
HD, the expanded polyQ domain is responsible for the formation and
deposition of intranuclear and cytoplasmic inclusion bodies com-
posed of ﬁbrillar htt aggregates in transgenic mouse models and HD
brain tissues [3–5].
An important hallmark of HD is that age-of-onset and disease sever-
ity are correlated with the length of the polyQ stretch. PolyQ repeats
smaller than 35 are not associated with disease, 36–39 repeats result
in reduced penetrance, 40–59 repeats result in adult age-of-onset, and
greater than 60 repeats yield juvenile forms of HD [6–8]. As mutant
htt fragments containing at least 39Q form detergent-insoluble protein
aggregates characteristic of amyloid ﬁbrils in a polyQ length dependent
manner [9,10], it was hypothesized that htt aggregation initiated by ex-
panded polyQ is associated with toxicity in HD. Furthermore, a series of
AFM studies demonstrated that htt aggregates into a variety of oligo-
mers and ﬁbrils in a polyQ length and concentration dependentmanner
[11]. Interestingly, synthetic polyQ peptides are capable of formingWest Virginia University, USA.
leiter).
rights reserved.ﬁbrils with polyQ domain lengths well below the disease threshold
[11,12]. The aggregation pathway and rate of aggregate formation of
these synthetic polyQ peptides are altered by the addition of ﬂanking
sequences associated with htt [13,14].
Upon the discovery that behavioral phenotype followed the ap-
pearance of intranuclear and cystoplasmic inclusion bodies in mouse
models, it was hypothesized that the formation of inclusions was
directly involved in HD pathology [3]. Mutant htt fragments in cell cul-
ture formed cytoplasmic and intranuclear inclusions in a polyQ depen-
dent manner [15–17]. However, the role of inclusions in HD was
challenged by studies demonstrating that inclusions might be protec-
tive or incidental while the smaller more diffuse population of aggre-
gates may represent toxic entities [16,18,19]. Crystallographic and
antibody studies have highlighted the diversity of htt exon1 con-
formers [20,21], demonstrating the complexity of potential aggrega-
tion starting points driven by polyQ expansion.
Several potential functions of htt have been postulated, providing
insight into possible modes of toxicity. Htt has been shown to aid in
orienting mitotic spindles during cell division [22], transporting vesi-
cles along microtubules [23], and associating with the endoplasmic
reticulum [24,25] and nucleus [26]. The ﬁrst 17 N-terminal amino
acids (Nt17) in htt exon1 have been shown to adopt a highly con-
served amphipathic α-helical structure with membrane binding
properties [24], pointing to the potential importance of htt exon1's
interaction with lipid membranes. The interaction and insertion of
htt with plasma membranes have been shown to be polyQ dependent
[27–29]. Thus, the availability of Nt17 as well as polyQ length appears
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intraventricular infusion of ganglioside GM1 induced phosphoryla-
tion of residues 13 and 16 within the 17 N-terminal amino acids
and attenuated htt toxicity and restored normal motor function [30].
As polyQ length modulates aggregation state, membrane associa-
tion, and onset and severity of disease, the extent of association and
morphology of toxic conformers at lipid interfaces may also be
polyQ length dependent. Here, we sought to systematically quantify
the role of polyQ length in htt exon1 aggregation at lipid membrane
interfaces and determine the impact of this aggregation on mem-
brane mechanical properties. We also investigate the role of Nt17 in
facilitating htt/lipid bilayer interaction. Due to the limitations of tradi-
tional light and electron microscopy approaches for studying hetero-
geneous mixtures of htt aggregates on biological surfaces, we used
atomic force microscopy (AFM) to characterize the morphology and
roughness of the supported model membranes. AFM yields three-
dimensional surface maps with nanometer resolution in solution
with the absence of artifacts from sample processing. By using a spe-
cialized variation of in situ tapping mode AFM called scanning probe
acceleration microscopy (SPAM), mechanical surface properties, such
as compression and adhesion, can be measured locally. Furthermore,
both techniques are operable in aqueous environments, making them
uniquely well suited for biologically relevant samples.
2. Materials and methods
2.1. Puriﬁcation of GST-htt-exon1 fusion proteins
Glutathione S-transferase (GST)-Htt exon1 fusion proteinswere pu-
riﬁed as previously described [31]. For experiments presentedhere, four
different htt exon1 fragments were used (Fig. 1a): (1) htt exon1(35Q),
which contains 35 repeat glutamines, (2) htt exon1(46Q), which con-
tains 46 repeat glutamines, (3) htt exon1(51Q), which contains 51 re-
peat glutamines, and (4) myc-htt exon1(53Q), which contains 53
repeat glutamines and an additional N-terminal myc-tag that is not
present in the other constructs. Brieﬂy, the GST-htt fusion proteins
were expressed by induction in Escherichia coli with isopropyl β-D-
thiogalactoside at 30 °C for 4 h. Lysozyme (0.5 mg/mL) was used to
lyse the cells. The fusion proteins were puriﬁed from lysate by using a
GST afﬁnity column and liquid chromatography (LPLC, BioRad or FPLC,
GE Pharmacia). Relevant fraction and purity was determined by gel
electrophoresis (Fig. 1b). Purity of the fusion proteins was consistently
greater than 90% for all polyQ lengths based on Coomassie blue staining.
Cleavage of the GST moiety by PreScission Protease (GE Healthcare,
Piscataway, NJ) or Factor Xa (Promega, Madison, WI) initiates aggrega-
tion (Fig. 1c). Fresh GST-htt exon1 fusion proteins were used for each
experiment. Solutions with all fusion proteins were centrifuged at
20,000 ×g for 30 min at 4 °C to remove preexisting aggregates prior
to the addition of the cleaving agent, and all experiments were carried
out in buffer A (50 mM Tris–HCl, pH 7.0, 150 mM NaCl, 1 mM DTT).
To ensure efﬁcient GST cleavage, the GST-htt exon1 fusion protein and
respective cleavage agents were incubated for 1 h on ice.
2.2. Preparation of defect free bilayers patches
Lyophilized total brain lipid extract (porcine) was purchased from
Avanti Polar Lipids (Alabaster, AL) and resuspended in phosphate
buffered saline (PBS) (pH 7.3) at a concentration of 1 mg/mL. By
using a liquid nitrogen ice bath, bilayers and multilayer lipid sheets
were formed by ﬁve cycles of freeze–thaw treatment. Vesicle forma-
tion within the lipid suspensions was promoted by bath sonication
for 30 min. All experiments were performed with the same lot of
lipids. 25 μL of the suspended vesicle solution, diluted with 25 μL of
PBS (pH 7.3), was added directly to the AFM ﬂuid cell and placed
onto freshly cleaved mica. Vesicles were allowed to absorb to the
mica and fuse together to form a defect free bilayer (40 × 40 μm).Once the bilayer formed, 2–3 washes with PBS were performed to re-
move excess lipid vesicles.
2.3. In situ AFM imaging conditions
In situ AFM experiments were performed with a Nanoscope V
MultiMode scanning probe microscope (Veeco, Santa Barbara, CA)
equipped with a sealable ﬂuid cell and a closed-loop vertical engage
J-scanner. Images were taken with V-shaped oxide-sharpened silicon
nitride cantilever with a nominal spring constant of 0.5 N/m (Veeco,
Santa Barbara, CA) or with diving board shaped silicon cantilevers
with a nominal spring constant of 0.1 N/m (VISTAprobes, Phoenix,
AZ). Scan rates were set at 1.95 Hz with cantilever drive frequencies
ranging from 7 to 9 kHz. Proteins were prepared as previously de-
scribed to a ﬁnal concentration of 20 μM in PBS at a pH 7–8 when
injected directly into a ﬂuid cell containing a defect-free bilayer. The
bilayer surface was continually imaged once the protein was injected.
For SPAM experiments, 5 × 1.25 μm tapping mode AFM images
were captured with 512 × 128 pixel resolution. A signal access module
(Veeco, Santa Barbara, CA) and CompuScope 14100 data acquisition
card (Gage, Lachine, Quebec) were used to capture the cantilever de-
ﬂection signal at 2.5 MS/s and 14-bit resolution with a vertical range
of 2 V. The cantilever deﬂection signals were ﬁltered with a sliding,
Fourier transform based harmonic comb ﬁlter, and the second deriva-
tive of the ﬁltered cantilever deﬂection signal was used to acquire tip
acceleration. Tip acceleration was multiplied by the effective cantilever
mass, meff, resulting in the recovery of the time-resolved tapping force
between the tip and sample [32]. Themeff was obtained via thermal can-
tilever calibration methods [33].
2.4. Image processing
AFM images were analyzed with Matlab equipped with the image
processing toolbox (Mathworks, Natick, MA). Physical dimensions
of aggregates were measured automatically in the following way
[34,35]: (1) Images were imported into Matlab. (2) A ﬂattening algo-
rithm was applied to correct for curvature due to the imaging process.
(3) Binary maps of aggregate location were created from the ﬂattened
images by using a height threshold. Thiswas accomplished by assigning
values of 0 or 1 to any pixel of the image that represented a height
belowor above the allocated threshold, respectively. (4) Discrete aggre-
gates were located by applying pattern recognition algorithms to the
binarymap. (5) Once a discrete aggregate was located, physical proper-
ties were measured automatically. Each aggregate was also assigned an
individual number so that aggregates chosen based on speciﬁc mea-
sured properties could be located, allowing us to verify that chosen
dimensions correspondent to speciﬁc aggregate types.
3. Results
3.1. Htt exon1 interacts with lipid bilayers in a polyQ length dependent
To determine the extent that htt exon1 interacts with lipid bilayers,
we prepared supported, model lipid membranes through fusion of total
brain lipid extract (TBLE) vesicles. The formation of supported lipid bi-
layers by vesicle fusion is well established [36–38], and such bilayers
preserve many of the properties (i.e., lateral ﬂuidity) of their free
membrane counterparts [36,37]. Moreover, TBLE bilayers represent an
appropriate model surface for studies aimed at elucidating the interac-
tion of htt with lipids as TBLE is comprised of a physiologically relevant
ratio of membrane components, i.e., acidic and neutral phospholipids,
gangliosides, cholesterol, sphingolipids, and isoprenoids. All experi-
ments were performed at 21–22 °C.
Defect free bilayers (as determined by AFM) were exposed to
htt exon1 proteins with various polyQ lengths (htt exon1(35Q),
htt exon1(46Q), and htt exon1(51Q)) that were puriﬁed from E. coli
Fig. 1. (a) Schematic representations (not to scale) of the GST-htt exon1 fusion proteins (htt exon1(35Q), (46Q), (51Q), and myc-htt exon1(53Q)) used in this study. The fusion
proteins contain a GST tag, which upon addition of Factor Xa or PreScission Protease, cleaves this tag and initiates aggregation. (b) Representative SDS-PAGE of the puriﬁed fusion
proteins demonstrating the relative purity of each sample. (c) SDS-PAGE demonstrating the efﬁciency of cleaving the GST tag of the different fusion proteins.
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moiety and initiate aggregation, Factor Xa was incubated with the
GST-exon1 fusion protein on ice for 1 h prior to exposure to the sup-
ported bilayer. At such a time point, the resulting htt exon1 prepara-
tions predominately contain monomers and small oligomers [11,34].
Exposure of the membrane to vehicle buffers containing no htt pro-
tein did not result in any changes in the bilayer morphology after
the initial injection and for at least 15 h after injection (Fig. 2a).
Upon the initial exposure of the TBLE bilayer to 20 μM freshly pre-
pared htt exon1(35Q), there was noticeable deposition of protein ag-
gregates on the bilayer. Within 1–3 h of exposure (Fig. 2b), there
were both regions of perturbed bilayer morphology (evidenced by
an increase in RMS surface roughness) and discrete, amorphous ag-
gregates of htt exon1(35Q) on or potentially in the bilayer. These ag-
gregates were stable and immobile on the bilayer surface. There were
also small numbers of oligomers, based on morphology, observed on
the surface. In successive images, these amorphous aggregates be-
came larger, increasing in volume. The extent of bilayer perturbed
by htt exon1(35Q) also increased with time. After 12 h (Fig. 2b) of
exposure to htt exon1(35Q), the extent of bilayer disruption
increased in area, indicating further disruption of the bilayer's struc-
tural integrity.WhenTBLEbilayerswere exposed 20 μMaliquots of htt exon1(46Q),
large, discrete patches of roughened bilayer also appeared within 1–4 h
(Fig. 2c) with a similar morphology, stability, and immobility as was ob-
served for htt exon1(35Q) on the lipid bilayer. The extent of bilayer dis-
ruption caused by htt exon1(46Q) increased with time. After ~12 h
(Fig. 2c) of exposure of htt exon1(46Q), a vast area of bilayer roughness
was observed. Htt exon1(46Q) aggregates also formed on the bilayer
surface.While therewere discrete oligomers observed, large amorphous
accumulations of htt exon1(46Q) that grew inmasswith timewere also
present.
When TBLE bilayers were exposed to 20 μM solutions of htt
exon1(51Q), extensive areas of the bilayer were disrupted (increased
roughness) and several aggregates accumulated on the bilayer within
1–3 h (Fig. 2d). The observed morphological changes associated with
the bilayer were similar to those observed at later time points when
exposed to htt exon1(35Q) or htt exon1(46Q). After ~12 h (Fig. 2d),
nearly the entire bilayer displayed a roughened morphology, indicative
of disrupted bilayer structural integrity. Interestingly, ﬁbrils of these
constructs were not observed, despite literature reports indicating
that these constructs form ﬁbrils without the presence of a lipid mem-
brane at similar concentration and timescales [11]. This observation
suggests that the bilayer either promotes the formation of aggregates
Fig. 2. Htt exon1 binds to and disrupts the morphology of TBLE bilayers. TBLE bilayers
were exposed to (a) buffer vehicle, fresh preparation of (b) htt exon1(35Q), (c) htt
exon1(46Q), or (d) htt exon1 (51Q). Images taken at different time points are presented
as 3D reconstructions (10 × 10 μm) with indicated zoomed in 2 × 2 μm areas presented
in 2D. In the 2D representations, green arrows indicate oligomers, pink arrows indicate
amorphous aggregates, and blue outlines areas of increased surface roughness.
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interaction with lipid membranes.
In an effort to quantify the extent of interaction between the TBLE
bilayer and different htt exon1 constructs, analysis of the AFM images
was performed. First, the (root mean squared) RMS roughness of the
perturbed regions of the bilayer was measured (Fig. 3a). A freshly
formed, defect-free bilayer had a RMS surface roughness of 0.25 ±
0.01 nmmeasured over a total of 40 μm2. To prevent error associated
with the size of the regions of disrupted bilayer structure, RMS rough-
ness measurements of areas that had been destabilized by htt exon1
constructs were restricted only to portions of the images containing
disruption, and thus excluding regions of the bilayer not altered by
the presence of htt exon1 from the analysis. RMS roughness measure-
ments are also highly dependent on the coverage of htt exon1 aggre-
gates present on the surface; therefore, aggregate structures were
ﬁltered out of the analysis.
Within the ﬁrst four hours of exposure to the different htt exon1
constructs, regions of the bilayer that were signiﬁcantly rougher
(p b 0.01) than unperturbed bilayer were observed for all three
htt exon1 proteins, and the measured roughness increased with in-
creasing polyQ length. That is, htt exon1(35Q) caused the smallest
increase in surface roughness (0.59 ± 0.07 nm), htt exon1(46Q)
induced a signiﬁcantly larger increase in surface roughness (1.48 ±
0.12 nm), and htt exon1(51Q) resulted in the largest increase in surface
roughness (2.58 ± 0.17 nm). After 12 h of exposure, the bilayer surface
roughness associatedwith exposure to all three htt exon1 constructs in-
creased. While the roughness associated with exposure to htt
exon1(35Q) (1.48 ± 0.19 nm) was still signiﬁcantly smaller compared
to the other two constructs, the increased roughness associatedwith htt
exon1(46Q) (5.80 ± 0.51 nm) and htt exon1(51Q) (6.79 ± 0.67 nm)
was similar, indicating that there may be an upper limit to the amount
of increased roughness associated with exposure to htt exon1 proteins
and that reaching this state occurs more rapidly with longer polyQ
length.
As the previous analysis was conﬁned just to regions of the bilayer
that exhibited increased roughness, we next wanted to determine the
extent of bilayer disruption as a function of polyQ length. To accomplish
these, we determined the percentage of the surface that displayed any
increased roughness (Fig. 3b). At early (1–4 h after) exposure and
later (12–16 h after) exposure there was a tendency for longer polyQ
lengths to be associated with a larger extent of bilayer disruption. At
the early time point, htt exon1(51Q) resulted in a signiﬁcantly
(p b 0.01) larger area of bilayer disruption compared to the other two
constructs. At 12–16 h (Fig. 3b), bilayers exposed to htt exon1 (46Q)
had a signiﬁcantly (p b 0.05) larger extent of disruption compared to
bilayers exposed to htt exon1 (35Q), and htt exon1(51Q) caused a
larger extent of bilayer disruption (p b 0.01) than htt exon1 (46Q). Col-
lectively, the two analyses demonstrate a rough dependence on polyQ
length on the disruption of bilayer integrity.
3.2. Nt17 facilitates the interaction of htt exon1 with lipid bilayers
To determine if Nt17 facilitates the interaction between htt exon1
and lipid bilayers, we compared the lipid interaction of myc-htt
exon1(53Q), which contains a ten amino acid long myc-tag as well as
11 more vector derived amino acids directly adjacent to htt exon1's
N-terminus, with that of htt exon1 (51Q), which only has three addi-
tional vector derived residues on the N-terminus. These two constructs
have similar length polyQ domains and have been shown to form ﬁbrils
at a similar rate in the absence of a surface [34]. We hypothesized that
the addition of the additional 21 amino acids, including the myc-tag,
to the N-terminus of htt exon1 would inhibit the ability of the protein
to bind the lipid bilayer. Myc-htt exon1 (53Q) was prepared in the
same manner as the htt exon1(51Q) construct; however, PreScission
Protease was used to cleave the GST moiety in htt proteins with the
myc-tag. A potential complication in interpreting these studies is that
Fig. 3. Htt exon1 disrupts TBLE bilayers in a polyQ length dependent manner. (a) Quantiﬁcation of root mean squared (RMS) surface roughness and (b) percent bilayer disrupted by
exposure to htt exon1(35Q), htt exon1(46Q), or htt exon1(51Q) at 1–4 h and 12–16 h as assessed by AFM images. ⁎ indicates p b 0.01.
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Factor Xa (Fig. 1c).
Upon injection of 20 μM myc-htt exon1(53Q) to the lipid bilayer,
discrete, oligomeric and some large amorphous aggregates appeared
on the bilayer within 1–4 h (Fig. 4). These aggregates were stable and
appeared to be immobile, as they appeared unaltered in subsequent
AFM images. Regions of increased surface roughness were also
observed. After ~12 h (Fig. 4) of exposure to myc-htt exon1(53Q), the
extent of bilayer disruption and the size and number of aggregates in-
creased. While similar aggregate morphologies compared to those ob-
served for htt exon1(51Q) were observed, highly-branched ﬁbrillar
structures of myc-htt exon1(53Q) also formed on the surface. These
ﬁbrillar structures still were morphologically different than ﬁbrils
observed for the same constructs without the presence of a lipid surface
[34].
We then used image analysis to quantitatively compare the impact
of bilayer exposure to htt exon1(51Q) and myc-htt exon1(53Q)
(Fig. 5). While both constructs increased the surface roughness of
the bilayer, the addition of the myc tag signiﬁcantly reduced the mag-
nitude of the surface roughness at both early (1.47 ± 0.07 nm) and
later (4.10 ± 0.51 nm) time points. Furthermore, the area of bilayer
affected (roughened) by the exposure to htt exon1 was also signiﬁ-
cantly impeded by the addition of the myc-tag, indicating that
blocking or altering the N-terminus of htt exon1 reduces the efﬁciencyFig. 4. Freshly prepared TBLE bilayers were exposed to 20 μM myc-htt exon1 (53Q).
AFM images of myc-htt exon1(53Q) aggregates on TBLE bilayers at 3 and 12 h. Images
are presented as 3D reconstructions (10 × 10 μm) with indicated zoomed in 2 × 2 μm
areas presented in 2D. In the 2D representations, green arrows indicate oligomers, pink
arrows indicate amorphous aggregates, and blue outlines areas of increased surface
roughness.of its interaction with lipid membranes. This reduced ability of
myc-htt exon1 (53Q) to deposit on and disrupt themembranewas ob-
served despite the higher efﬁciency of the PreScission Protease, which
would result in a larger amount of free peptide.
3.3. Pre-aggregation inhibits the interaction of htt exon1 with
lipid bilayers
In order to determine if larger htt aggregates directly interact with
lipid bilayers, TBLE bilayers were exposed to pre-aggregated (8 h of in-
cubation)myc-htt exon1 (53Q). At this time point,myc-htt exon1(53Q)
was predominately aggregated into a variety of oligomers and large ﬁ-
brils [11,34]. Upon injection of the 20 μM pre-aggregated myc-htt
exon1(53Q) into the ﬂuid cell, little to no interaction with the bilayer
was observed as determined by the appearance of aggregates or in-
crease surface roughness (Fig. 6). The bilayers remained stable and
unaltered as assessed by AFM for over 24 h.
3.4. Htt exon1 induces mechanical changes in lipid bilayers
To determine if exposure to htt exon1 altered bilayer mechanics,
SPAM was used to directly assess bilayer rigidity and adhesive prop-
erties by reconstructing the time-resolved tip/sample tapping forces
associated with imaging the surface with tapping mode AFM in solu-
tion. While the total force per tapping event remains constant at any
given set of AFM imaging parameters, speciﬁc features of the time-
resolved tapping force are sensitive mechanical properties of the sur-
faces [39,40]. Speciﬁcally, the maximum tapping force (Fmax), deﬁned
as the peak or largest positive force experienced between the tip and
surface during one tapping event, increases with larger values of sur-
face elastic modulus with a power law dependence.
[40,41]. Additionally, the minimum tapping force (Fmin), deﬁned
as the peak or largest negative force experienced between the tip
and surface during one tapping event, is directly proportional to the
adhesive energy between the tip and surface. As a result, monitoring
Fmax and Fmin while obtaining an AFM image allows for mapping the
relative rigidity and adhesive properties of the bilayer, which can be
directly associated with topographical features of the surface.
Force maps, as well as histograms of the forces associated with
every tapping event, were constructed of TBLE bilayers exposed
to htt exon1(51Q) (Fig. 7). The Fmax associated with regions of the bi-
layer perturbed (increased surface roughness) by exposure to htt
exon1(51Q) was signiﬁcantly reduced in magnitude, indicating that
a softening or decrease in the elastic modulus of these regions com-
pared to unperturbed regions of the bilayer (Fig. 7a). The magnitude
of Fmin associated with the perturbed regions of the bilayer also
decreased compared to unperturbed regions of the bilayer (Fig. 7b),
Fig. 5. Addition of an N-terminal myc tag as well as other vector derived residues inhibits the ability of htt exon1 to disrupt TBLE bilayers. (a) Quantiﬁcation of root mean squared
(RMS) surface roughness and (b) percent bilayer disrupted by exposure to htt exon1(51Q) or myc-htt exon1(53Q) at 1–4 h and 12–16 h as assessed by AFM images. ⁎ indicates
p b 0.01.
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tip and bilayer in the regions with increased surface roughness.
These observed changes in rigidity and adhesion are consistent with
a decreased order of lipid component packing required to compensate
for protein insertion/binding, thus resulting in a rougher bilayer that is
more easily compressed by the AFM tip.
4. Discussion
In this study, we determined how the interaction of htt exon1
with TBLE bilayers is polyQ length dependent, facilitated by the avail-
ability of the Nt17 domain of htt, and aggregation state. We also eval-
uated the mechanical impact on lipid bilayers of exposure to htt
exon1. The culmination of these ﬁndings emphasizes the importance
of polyQ length and Nt17 on aggregation rates and resulting aggre-
gate morphologies of mutant htt exon1 in the presence of lipid mem-
branes. Our results support the notion that monomeric htt and/or
pre-ﬁbrillar aggregates may play a causative role in HD pathogenesis
by directly binding subcellular surfaces and directly altering mem-
brane integrity. While we used TBLE bilayers as model membranes
for these studies, it is unlikely that this membrane would perfectly
mimic the composition of lipids in actual cellular and subcellular sur-
faces as membranes in the brain are heterogeneous depending on cell
type, brain regions, and intracellular compartments. As a result, fur-
ther studies are justiﬁed to elucidate the interaction of htt with differ-
ent model membranes and cellular surfaces.
Several aggregation pathways have been proposed for the forma-
tion of ﬁbrils of polyQ-containing proteins in free solution. Commonly,
two aggregation schemes are proposed. The ﬁrst requires the re-
arrangement of a monomer to a thermodynamically unfavorable con-
formation that directly nucleates ﬁbrillization [12]. The second sce-
nario proceeds via the formation of soluble oligomeric intermediates
that undergo a structural re-arrangement leading to ﬁbril formation
[11,42,43]. Some studies suggest that these two schemes are notFig. 6. Freshly prepared TBLE bilayers were exposed to 20 μM myc-htt exon1(53Q).
AFM images of myc-htt exon1(53Q) aggregates on TBLE bilayers at 1 and 24 h.
Green arrows indicate oligomeric aggregates formed on the bilayer surface.mutually exclusive [11]. In general, it appears that pure polyQ peptide,
i.e., no ﬂanking sequences, prefers to aggregate from monomers di-
rectly to ﬁbrils [44–46]; although, some studies have questioned this
interpretation [47,48]. It has been suggested that the addition of
ﬂanking sequences, in particular Nt17, can shift the aggregationFig. 7. Exposing TBLE bilayers to htt exon1(51Q) resulted in local regions of reduced
Young's modulus and adhesion to the AFM tip. (a) Topography image of TBLE bilayer
exposed to htt exon1(51Q). SPAM images and histograms of (b) the maximum tapping
force (Fmax) and (c) the minimum tapping force (Fmin) that correspond to the topogra-
phy image are also presented. The reduced Fmax associated with the regions of the
bilayer with perturbed morphology indicates a lower elastic modulus. The reduced
Fmin associated with the regions of the bilayer with perturbed morphology indicates
reduced adhesive interaction between the bilayer and AFM tip.
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[14,42,43]. However, these aggregation schemes can be further com-
plicated by environmental factors such as surfaces [49], and our
study indicates that lipid membranes can further modulate the aggre-
gation process, favoring the formation of amorphous accumulations of
htt exon1 and small oligomers.
Our studies indicate that htt exon1/lipid interaction is highly de-
pendent on polyQ length. While previous studies indicate that htt
exon1 and synthetic polyQ peptides aggregate into numerous differ-
ent species [11,42,43], including ﬁbrils and oligomers, our results
demonstrate that amorphous accumulations of htt exon1 are the pre-
dominant aggregate species formed at the liquid/lipid interface. How-
ever, some oligomers were bound to the bilayer surface, and ﬁbril-
like morphologies were observed when a myc-tag was added to the
N-terminus of htt exon1.
While htt fragments with expanded polyQ domains are predomi-
nately located in microscopic inclusion bodies in the cytoplasm and
nucleus in HD brains [3], htt has been shown to be directly associated
with a variety of membranous surfaces such as mitochondria, endo-
plasmic reticulum, tubulovesicles, endosomes, lysosomes and synap-
tic vesicles [4,50]. The environments associated with these subcellular
membrane surfaces could profoundly affect the aggregation of htt
with expanded polyQ domains. For example, lipid membranes could
act as nucleation sites by promoting/stabilizing speciﬁc aggregate
prone conformation, orienting monomers to faciliate aggregation, or
by creating local areas of high htt concentration. The potential role
of such membranes in htt aggregation is supported by observations
in cellular models that membraneous structures are directly incorpo-
rated onto the surfaces of htt inclusion bodies [51] and that htt aggre-
gates accumulate lipids in transgenic mice [52,53]. N-terminal
fragments of htt are associated with membrane when isolated from
HD brains [54]. Studies with large unimolecular vesicles demonstrat-
ed that association of htt with lipid surfaces was highly dependent on
phospholipid content [29].
In our study, the ability of htt exon1 to directly interact with TBLE
bilayers is directly correlated to length of the polyQ domain. It has
been well established in synthetic polyQ peptides that the longer
the polyQ stretch the faster the rate of aggregation in free solution
[43–46,55,56]. This aggregation rate dependence on polyQ length
has been experimentally veriﬁed in htt exon1 constructs [11], and
these observations are consistent with a causative role for htt aggre-
gation in HD pathogenesis. In light of these studies, it would be rea-
sonable to interpret the observed polyQ-length dependence on htt
interaction arising from the increased aggregation rate with longer
polyQ domains. However, the aforementioned aggregation studies
were not performed in the presence of a lipid membrane, and the ag-
gregate morphologies were distinctly different compared to the ag-
gregates observed on TBLE bilayer here, suggesting there may be
other mitigating factors involved. For example, a recent study using
a variety of synthetic polyQ peptides suggested that there was a
polyQ length dependence on the formation and stability of the am-
phipathic α-helix associated with Nt17 [42]. While this Nt17
α-helix has been linked to the formation of oligomers [42,43], it
also targets membranes [24,52,57,58]. The stabilization of this Nt17
α-helix based on polyQ length may be playing an indirect role critical
to the association of htt exon1 with lipid membranes, reinforcing the
polyQ-length dependence on htt/lipid interactions.
The notion that Nt17 facilitates the interaction between htt and
lipid membranes is further supported by our observations that an
N-terminal myc-tag can inhibit the ability of htt exon1 to directly in-
teract with TBLE bilayers. This suggests that Nt17's amphipathic
α-helix is either sterically blocked or structurally altered by the
myc-tag, reducing the efﬁciency by which it binds bilayers. Notably,
there was a distinct morphological difference between aggregates of
myc-htt exon1(53Q) on the bilayer compared to aggregates com-
prised of htt exon1(51Q). As a result, there appears to be a myc-tagfacilitated mechanism to form highly-branched, ﬁbril-like aggregates
on the bilayer surface. Such observations are interesting in light of
studies that indicate that exogenous tags to htt constructs alter toxic-
ity in yeast models of HD [59]. Recent studies have even noted
post-translational modiﬁcations to Nt17 alter aggregation state [60]
and subcellular localization [61] of htt, and these modiﬁcations
could further modify the interaction of htt with lipid bilayers.
The Nt17 domain promotes the formation of oligomeric intermedi-
ates on pathway to ﬁbril formation [42,43], whereas, pure polyQ pep-
tides prefer to form ﬁbrils directly from monomer precursors [62]. The
importance of Nt17 in promoting oligomer formation has also been
demonstrated in htt exon1, as the addition of the same N-terminal
myc-tag used in this study reduced oligomer formation without any ef-
fect onﬁbrillization [34].While targeting theNt17has been demonstrat-
ed to alter htt aggregation [60], the efﬁciency of such a strategy may be
reduced due the presence of lipid surfaces. Such a scenariowas observed
experimentally when (−)-epigallocatechin gallate (EGCG) was less ef-
fective at inhibiting aggregation of human islet amyloid polypeptide at
a phospholipid interface [63].
Our mechanical analysis of TBLE bilayers demonstrates that expo-
sure to htt exon1 locally alters the compressibility of the bilayer and re-
duces the adhesive interaction between the AFM tip and bilayer. These
mechanical alterations to the lipid bilayer induced by htt exon1 could
underlie membrane dysfunction previously observed in animal models
[3,26]. Themechanical changes could be due to a local disordering of bi-
layer lipid components to accommodate the binding and aggregation of
htt exon1 within the bilayer. Such a scenario is consistent with the in-
creased surface roughness associated with these mechanically altered
domains. Disordering of the lipid bilayer induced by expanded htt
exon1 could jeopardize membrane integrity and lead directly to mem-
brane dysfunction. Lipid/htt interactions are also relevant in the trafﬁck-
ing of htt within the cell [64–66]. Previous studies have speculated that
lipid mechanics are directly correlated with dysfunction and disease
[67–69] as elasticity and adhesion are hypothesized to inﬂuence cellular
and sub-cellular stabilities. Understanding how alterations in lipid
stability and mechanics relate to polyQ length and the N-terminal
α-helix could aid in identifying the precise mechanism that mediates
pathogenesis in HD.
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